Apollo Medical - AMEH Stock Forecast, Price & News

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Apollo Medical in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" AMEH shares.
View AMEH analyst ratings or view top-rated stocks.

3 Wall Street research analysts have issued 12 month price objectives for Apollo Medical's stock. Their AMEH share price forecasts range from $57.00 to $57.00. On average, they expect the company's share price to reach $57.00 in the next year. This suggests a possible upside of 108.9% from the stock's current price.
View analysts price targets for AMEH or view top-rated stocks among Wall Street analysts.

Apollo Medical's stock was trading at $73.48 at the start of the year. Since then, AMEH shares have decreased by 62.9% and is now trading at $27.29.
View the best growth stocks for 2022 here.

Apollo Medical saw a drop in short interest in November. As of November 15th, there was short interest totaling 4,030,000 shares, a drop of 8.8% from the October 31st total of 4,420,000 shares. Based on an average daily trading volume, of 272,500 shares, the short-interest ratio is presently 14.8 days. Approximately 10.6% of the shares of the stock are sold short.
View Apollo Medical's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our AMEH earnings forecast.

Apollo Medical Holdings, Inc. (NASDAQ:AMEH) announced its earnings results on Thursday, November, 4th. The company reported $0.69 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.35. The firm had revenue of $227.12 million for the quarter. Apollo Medical had a net margin of 6.26% and a trailing twelve-month return on equity of 13.49%. During the same quarter last year, the company posted $0.45 EPS.

Apollo Medical updated its FY 2022 earnings guidance on Thursday, November, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.09 billion-$1.11 billion, compared to the consensus revenue estimate of $1.07 billion.

15 employees have rated Apollo Medical Chief Executive Officer Thomas Lam on Glassdoor.com. Thomas Lam has an approval rating of 43% among the company's employees. This puts Thomas Lam in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. 28.0% of employees surveyed would recommend working at Apollo Medical to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include PayPal (PYPL), SEA (SE), Mastercard (MA), NVIDIA (NVDA), Walt Disney (DIS), Lululemon Athletica (LULU), Enphase Energy (ENPH), Main Street Capital (MAIN), Block (SQ) and Exxon Mobil (XOM).

Apollo Medical trades on the NASDAQ under the ticker symbol "AMEH."

Apollo Medical's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (10.84%), Vanguard Group Inc. (7.52%), State Street Corp (2.31%), Dimensional Fund Advisors LP (0.67%), Bank of New York Mellon Corp (0.64%) and Steel Peak Wealth Management LLC (0.48%). Insiders that own company stock include Adrian Vazquez, Albert Waichow Young, Brandon Sim, Eric Chin, Linda Marsh, Physicians Of Californi Allied and Thomas S Lam.
View institutional ownership trends.

Shares of AMEH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AMEH stock can currently be purchased for approximately $27.29.

Apollo Medical (NASDAQ:AMEH) has a market capitalization of $1.55 billion and generates $773.91 million in revenue each year. The company earns $73.86 million in net income (profit) each year or $1.42 on an earnings per share basis.

The company employs 1,133 workers across the globe.

Apollo Medical's mailing address is 1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA CA, 91801. The official website for the company is www.apollomed.net. The company can be reached via phone at (626) 943-6491, via email at investors@apollomed.net, or via fax at 818-839-5190.